؉ fractions contain progenitors that do not require the contact. This co-culture system should be useful for the study of early human B-lymphopoiesis.
Introduction
Lymphocytes are derived from a small population of hematopoietic stem cells, as are myeloid lineage cells such as red cells, granulocytes, macrophages, and platelets. [1] [2] [3] The mechanisms that regulate the early stages of murine B-lymphopoiesis from primitive hematopoietic progenitors have been extensively studied. Cumano et al 4 developed a stroma celldependent clonal culture assay in which bipotential progenitors from murine day-12 fetal liver differentiated along Blymphoid and macrophage lineages in the presence of stromal cells and interleukin (IL)-7. They subsequently found that a combination of stem cell factor (SCF) and IL-11 can replace the stromal cells. 5 Hirayama et al [6] [7] [8] established a stroma cellfree clonal culture assay and demonstrated that the combinations of SCF, FLT-3/FLK-2 ligand, or IL-4 with one of the synergistic factors such as IL-6, IL-11, IL-12, or granulocyte colony-stimulating factor (G-CSF) can support the proliferation of murine bone marrow (BM) lymphohematopoietic progenitors that are capable of differentiation along both B-lymphoid and multi-myeloid lineages. They also reported that the However, in contrast, little is known about the mechanisms that regulate the early stages of human B-lymphopoiesis.
The late stages of B-lymphopoiesis from committed Blymphoid progenitors to mature B cells have also been extensively studied using murine systems. [11] [12] [13] [14] The phenotypes of the progenitors have been well characterized on the basis of their rearrangement status of immunoglobulin (Ig) genes and growth factor requirement. 15, 16 In addition, the differentiation mechanisms have been studied at the level of transcription factors. 17, 18 Again, in contrast, little information is available for the late stages of human B-lymphopoiesis.
One of the reasons for the paucity of studies of human Blymphopoiesis is the lack of suitable in vitro culture systems. In the present study, we established a sensitive culture system for human B-lymphopoiesis using a cocktail of cytokines and a monolayer of the murine BM-derived stroma cell line, MS-5. 19, 20 In this culture, 3 × 10 3 CD34 + cells produced approximately 1 × 10 6 CD19 + cells every week, and as little as 2 × 10 2 CD34 + cells consistently yielded CD19 + cells. In addition, CD19
+ cells finally differentiated into surface IgM (sIgM + ) mature B cells. This culture system should provide an in vitro culture assay to study the mechanisms regulating both the early and late stages of human B-lymphopoiesis.
Materials and methods

Cells
Raji (human B cell line) cells were maintained in RPMI1640 (Life Technologies, Tokyo, Japan) containing 10% FCS (Hyclone, Logan, UT, USA). The murine BM-derived stroma cell line MS-5 originated from C3H/HeNSIc mouse BM cells, and is a slowly proliferating, radio-resistant stroma cell line. 19 The MS-5 cells were maintained in ␣-MEM (Life Technologies) with 10% FCS.
Human cord blood was collected with consent after fullterm deliveries. The cord blood was layered on the separation medium (Ficoll-Paque, density 1.077 g/ml; Pharmacia Biotech, Uppsala, Sweden) and centrifuged at 400 g for 30 min at room temperature, then the mononuclear layer was aspirated. The cells were washed, suspended in ␣-MEM with 10% FCS, then depleted of adherent cells by overnight incu-765 bation at 37°C and collected. The non-adherent mononuclear cells were further enriched for CD34 + cells using a MACS CD34 Progenitor Cell Isolation Kit (Miltenyi Biotec, BergischGladbach, Germany) as described in detail elsewhere. 21, 22 Briefly, nonadherent mononuclear cells were indirectly magnetically labeled using a hapten-conjugated primary monoclonal antibody (mAb) against CD34 (QBEND/10) and an antihapten antibody (Ab) coupled to MACS MicroBeads. The magnetically labeled CD34 + cells were enriched on a positive selection column. This separation procedure was repeated twice, and the purity of CD34
+ cells was more than 90%. For the further purification of several subpopulations of CD34 + cells, CD34
+ cells semi-purified using one selection column were stained with mAbs such as fluorescein isothiocyanate (FITC)-conjugated anti-CD34 (HPCA-2; Nippon Becton Dickinson (BD), Tokyo, Japan), phycoerythrin (PE)-conjugated anti-CD19, anti-CD13, and anti-CD33 (Dako Japan, Kyoto, Japan), and then sorted with the use of cell sorter equipment (Epics Elite; Coulter, Tokyo, Japan). For the purification of CD34 +
CD19
+ cells, the cells that had passed through the first MACS separation column were used as CD34
− cells and sorted for CD34
− CD19 + cells. The purity of the sorted cells was more than 95%.
Cytokines
Human recombinant (r) G-CSF was a generous gift from Chugai Pharmaceutical Co. (Tokyo, Japan). Human rSCF was provided by Kirin Brewery Co. (Tokyo, Japan). The concentrations of the cytokines were 10 ng/ml, and preliminary data indicated that this was the optimal concentration.
Flow cytometry analysis
The surface phenotype of cultured cells was determined with a flowcytometer (Epics XL; Coulter). FITC-conjugated or PEconjugated control Abs or mAbs against the following antigens were purchased from Dako or an otherwise stated vender: CD3, CD10, CD14, CD19, CD20, CD33 IgM and CD56 (Coulter). Mouse IgG1-FITC, rabbit Ig F(ab′) 2 fragment-FITC, and mouse IgG1-PE were used as control Abs. The staining of cells with fluorochrome-conjugated Abs was conducted by the industrial instruction method, and then propidium iodide (Sigma Chemicals, St Louis, MO, USA) was added at a final concentration of 1 g/ml to selectively identify dead cells.
Cell culture 
Polymerase chain reaction (PCR) for Ig clonality
A modified semi-nested PCR technique was used to amplify the CDR3 comprising the V-D-J region of the Ig heavy-chain gene. 23, 24 For the first round of amplification, the framework 3 consensus primer (5′-ACACGGC[C/T][G/C]TGTATTACTGT-3′) and a downstream consensus primer directed at the joining region (LJH: 5′-TGAGGAGACGGTGACC-3′) were used. For the second round of PCR, the Fr3 primer was used in conjunction with an inner downstream primer (VLJH: 5′-GTGAC-CAGGGTNCCTTGGCCCCAG-3′). In each round, the PCR mixture contained 10 mM Tris (pH 8.3), 50 mM KCl, 200 M each dNTP, 3 mM MgCl 2 and 2.5 units of Ampli-Taq Gold (Perkin Elmer Cetus, Uberlingen, Germany) in a 20 l total reaction mixture. The first-round PCR contained 125 ng of DNA, and the second-round PCR contained 1 l of a 1 in 20 dilution of the first-round PCR product as a template. DNA from peripheral blood mononuclear cells (PBMC), Raji and pre-B cells was extracted with a QIAamp Blood Kit (Qiagen, Chatsworth, CA, USA) according to the manufacturer's protocol. The PCR amplification cycles were as follows: activation of polymerase 95°C for 10 min, followed by 30 cycles of 95°C for 30 s; 50°C for 30 s; and 72°C for 30 s; the PCR was terminated by a 10 min extension at 72°C. Use of the primers would be expected to generate a fragment between 80 and 120 bp in length. The reaction product was analyzed on a 4% agarose gel.
Results
Co-culture of CD34
+ cells with MS-5 monolayer
To establish a culture system that might support the growth and differentiation of B-lymphoid lineage cells from human CD34 + primitive progenitors, we used a monolayer of the murine stromal cell line MS-5, which has been reported to support the maintenance of spleen colony-forming cells 19 and human primitive hematopoietic progenitors. 20 In addition, we also utilized SCF and G-CSF, since they synergistically support the early proliferation of murine lymphohematopoietic progenitors that can differentiate along both myeloid and Blymphoid lineages, 7 and since SCF enhances the proliferation of committed B cell progenitors in both murine and human systems. 25, 26 We first tested two conditions; one was the cytokines SCF and G-CSF plus an MS-5 monolayer, and the other was SCF and G-CSF alone. Five hundred enriched CD34 + cells were plated in six-well plates in the presence of SCF and G-CSF with or without an MS-5 monolayer. Medium changes were carried out weekly, ensuring that the cells were not disturbed. Four weeks later, the non-adherent cells in the culture with the cytokines and MS-5 monolayer, and all of the cells in the culture with the cytokines alone were collected and analyzed for the presence of CD19 + B-lymphoid lineage cells. From the cultures with the cytokines alone, less than 2 × 10 5 cells were recovered, and most of the cells had high forward and side scatter and did not express CD19. In contrast, the cultures with the MS-5 monolayer each produced approximately 1-2 × 10 6 non-adherent cells, 60-90% of which showed low forward and side scatter and were positive for CD19. In Figure 1 , the representative results of three experiments are presented.
We next examined the effects of the cytokines. Three thousand CD34 + cells were plated on an MS-5 cell monolayer in the presence or absence of SCF and G-CSF. At every medium change, all of the nonadherent floating cells were harvested. The total cell number of the non-adherent cells and their expression of CD19, CD14 and CD33 were serially analyzed. In addition, a cytological examination was performed. In the . A representative result of three experiments is shown in Figure 2 . Photomicrographs of the cells har- vested after 2 and 4 weeks of culture are shown in Figure 3a and b, respectively. When the culture was started in the absence of the growth factors, the total cells and CD19
+ cells increased slowly for 3 weeks and then decreased. However, the peaks were three to five times lower than those of the culture with the cytokines, and CD14 + and or CD33 + cells were observed only sporadically (Figure 2) . The experiments using differing concentrations of CD34 + cells revealed that as few as 2 × 10 2 CD34 + cells produced continuous growth of CD19
+ cells in the presence of an MS-5 monolayer and the cytokines (data not shown).
Purification of B cell progenitor cells
In order to test whether the CD19 + cells were generated by CD34 +
CD19
− primitive progenitors and not by CD19 + committed B-lymphoid progenitors, we sorted three populations of cells; CD34 Figure 6 . Most of the sIgM + cells expressed CD20, and none of the nonadherent cells were positive for T cell markers such as CD3, CD4, and CD8 (data not shown).
To further confirm the B cell nature of the generated cells in the culture, we performed a PCR amplification of CDR region of Ig heavy-chain gene using consensus primers for the V and J regions gene. With this approach, a monoclonal B 
− cells were sorted from the CD34 + population purified by the MACS kit. cell population will be characterized by amplified DNA of a single size, while a polyclonal B cell population will be characterized by amplified DNA of a range of sizes. 23, 24 As shown in Figure 7 , the broad smear of polyclonal amplified DNA was observed in PBMC (lane 1), whereas a discrete amplified band approximately 100 bp in length was seen in a monoclonal population of the B-lymphoid cell line Raji (lane 2). Two cases of nonadherent cells harvested after 4 weeks of co-culture (lanes 3 and 4) generated a diffuse smear of amplified DNA, indicating that the polyclonal rearrangement of immunoglobulin-chain gene was carried out.
Comparison of cell-cell contact and cell-cell noncontact culture systems for B cell development It has been reported that cell-cell interactions between stroma and progenitor cells play important roles in early Blymphopoiesis in both murine 11, [27] [28] [29] [30] [31] and human [32] [33] [34] [35] systems. Therefore, to elucidate whether cell-cell interactions between MS-5 cells and progenitor cells are required for the generation of CD19
+ cells in our culture, CD34 + cells were cultured with or without the 0.45 m microporous filter on an MS-5 cell layer. As shown in Figure 8 , the filter separation had no effect on the generation of CD19 + cells. Since CD34 + progenitors are considered to be heterogeneous in the maturation stage, we further enriched CD34
+ cells for more primitive progenitors, CD34 + CD19 − CD13 − CD33 − cells, and tested whether they can produce CD19 + cells in the culture with or without a separation filter. The results of a representative experiment are shown in Figure 9 . The enriched progenitors revealed the capacity to give rise to CD19 + cells in the culture without a filter. In contrast, CD19
+ cells were not generated in the culture with a filter.
Discussion
In the present study, we found that the murine BM-derived stroma cell line MS-5 supported the proliferation of human cord blood CD34 + progenitors and their differentiation into CD19 + cells and the final maturation to sIgM + B cells in harmony with SCF and G-CSF. In our culture condition, after a wave of myeloid lineage cell production, a marked generation of CD19
+ cells was observed (a 1 × 10 3 ෂ1 × 10 4 -fold increase in cell number). Since this activity was observed in the CD34 + CD19 − cell population, but not in the CD34
− CD19 + cell populations, it is evident that this marked production of CD19 + cells is due not to the mere expansion of CD19 + cells, but rather to the differentiation of more immature B-lymphoid progenitors. Indeed, we recently found that micromanipulated single cord blood CD34
+ cells differentiated in our culture along both myeloid and B-lymphoid lin-
Figure 6
Sequential two-color analysis of nonadherent cells for expression of CD19 and sIgM. 1 × 10 3 CD34
+ CD19 − cells were cultured on an MS-5 monolayer with SCF and G-CSF. Nonadherent cells were harvested from the cultures weekly, labeled with fluorochromeconjugated anti-CD19 and anti-IgM Ab, and analyzed on a flowcytometer.
eages (submitted). These results indicate that this culture system supports very early stages of B-lymphopoiesis and provides opportunities to study the mechanisms of commitment to B-lymphoid lineage.
Rawlings et al 34, 36 established a stroma cell-dependent culture assay in which human cord blood CD34
+ cells extensively produce CD19
+ cells, and they subsequently found that 
CD33
− cells were plated in the presence of SCF and G-CSF either directly on to an MS-5 cell layer (contact) or in cell culture inserts that separated the cells from the MS-5 cells by a microporous membrane (non-contact). The cells were harvested after 7 weeks of culture.
CD19
+ cells are generated from CD34 + CD38 − primitive hematopoietic progenitors. Therefore, their culture may provide similar conditions that are sufficient for studying the early 3stages of B-lymphopoiesis, as does our culture. Recently Berardi et al 37 reported a similar culture system to ours for human cord blood progenitors, in which single
+ cells on a monolayer of MS-5 cells in the absence of exogenous cytokines. The striking difference between their culture system and ours is that we used SCF and G-CSF in addition to the MS-5 monolayer. This addition of the two cytokines greatly enhanced the production of CD19 + cells as shown in Figure 1 .
Considering that both SCF 38, 39 and G-CSF 40, 41 support the early proliferation of primitive hematopoietic progenitors in murine as well as human systems, and, especially that SCF and G-CSF synergistically support the proliferation of murine primitive hematopoietic progenitors and their early differentiation along both myeloid and B-lymphoid lineages, 7 it is likely that SCF and G-CSF acted on primitive hematopoietic progenitors by themselves or together with MS-5 cells and supported their proliferation and early differentiation along the B-lymphoid lineage. We are now pursuing the cytokine combinations that can replace MS-5 cells. In addition to their effects on primitive progenitors, SCF and G-CSF may support the proliferation and differentiation of committed B-lymphoid progenitors. Although the stimulatory effects of SCF on murine committed B-lymphoid progenitors are evident, 25 these effects in the human system are controversial. Saeland's group 26 suggested positive roles of SCF, whereas Ryan et al 42 reported that anti-SCF Ab had no inhibitory effect on the in vitro TdT + colony formation from CD34 +
CD10
− human BM cells. In addition, Namikawa et al 43 observed stimulatory roles of FLT3/FLK2 ligand, but not of SCF on the proliferation of CD34 + CD19 + pro-B cells. In regard to G-CSF, there is no report about its stimulatory effects on committed B-lymphoid progenitors, to our knowledge. However, we observed that the in vivo administration of G-CSF (5ෂ10 g/kg/day × 4 days) for peripheral blood stem cell collection resulted in a twofold increase of CD19 + cells in peripheral blood (unpublished data). This result may reflect a direct effect of G-CSF on committed B-lymphoid cells. The details of this phenomenon need to be clarified.
Several culture systems have been reported for the study of human B-lymphopoiesis, most of which failed to support the differentiation of mature IgM + B cells. In our culture, we observed the development of CD19 + IgM + mature B cells after 4 weeks of culture. The B cell nature was further confirmed by the polyclonal rearrangement of the immunoglobulin-chain gene. In preliminary experiments using micromanipulated single CD34
+ cells, we found that a significant number of CD34 + progenitors are capable of differentiation to mature myeloid cells and IgM + mature B cells. This unequivocally indicates that the IgM + mature B cells generated in our culture were derived not from the contamination of mature B cells, but rather from primitive hematopoietic progenitors. Namikawa et al 43 recently reported that human fetal BM CD34 + CD19 + pro-B cells proliferated in response to FLT3/FLK2 ligand, IL-7 and IL-3, and that some of the cells (ෂ6%) finally differentiated to CD19 + IgM + mature B cells. Maximal cell growth was observed after 3 weeks of culture, and the expansion of the cell numbers was 15-to 30-fold. The presence of mouse BM stromal cells further enhanced the proliferation and differentiation of CD19 + cells by two-fold. Some lines of stroma cells such as the one used by Namikawa's group and MS-5 in our system may have stimulatory roles that enhance the maturation of CD19 + cells to mature IgM + B cells. It has been demonstrated in both murine 11, [27] [28] [29] [30] [31] and human [32] [33] [34] [35] systems that cell-cell contact between B-lymphoid progenitors and stromal cells plays important roles in Blymphopoiesis. In our culture, the separation of CD34 + cells and the MS-5 monolayer with a microporous filter did not suppress the generation of CD19 + cells. However, in contrast, when more primitive CD34 +
CD19
− CD13 − CD33 − cells were utilized, the filter separation abrogated CD19 + cell production. This indicates the involvement of cell-cell contactmediated signals between stromal cells and the more primitive subpopulation of CD34 + progenitors. Little is known about the nature of these signals. It remains to be elucidated.
